JPMorgan Chase & Co’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.1K | Buy |
7,540
+7,519
| +35,805% | +$41K | ﹤0.01% | 5155 |
|
|
2025
Q1 | $116 | Sell |
21
-3
| -13% | -$17 | ﹤0.01% | 5981 |
|
|
2024
Q4 | $120 | Sell |
24
-1
| -4% | -$5 | ﹤0.01% | 5929 |
|
|
2024
Q3 | $115 | Buy |
25
+5
| +25% | +$23 | ﹤0.01% | 5910 |
|
|
2024
Q2 | $110 | Sell |
20
-10,539
| -100% | -$58K | ﹤0.01% | 5846 |
|
|
2024
Q1 | $103K | Buy |
+10,559
| New | +$103K | ﹤0.01% | 4720 |
|
|
2022
Q1 | – | Sell |
-55,000
| Closed | -$543K | – | 5943 |
|
|
2021
Q4 | $543K | Sell |
55,000
-195,210
| -78% | -$1.93M | ﹤0.01% | 4016 |
|
|
2021
Q3 | $2.49M | Buy |
250,210
+250,000
| +119,048% | +$2.48M | ﹤0.01% | 3031 |
|
|
2021
Q2 | $2K | Buy |
+210
| New | +$2K | ﹤0.01% | 5379 |
|